Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPSQ2FY26 Operational PAT at ₹1,403m and EPS at ₹15.2, Grew 84% YoY".
Press Release Oct 31 2025
Earlier from Strides Pharma Science
- Strides Pharma Science: Intimation on Board Meeting scheduled for Oct 31, 2025
- Press Release Oct 17 2025